Vaccination in paediatric patients with auto-immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendations

M. W. Heijstek, L. M. Ott de Bruin, Raymond Borrow, F. van der Klis, I. Koné-Paut, A. Fasth, K. Minden, A. Ravelli, M. Abinun, G. Pileggi, M. Borte, M. Bijl, N. M. Wulffraat

Research output: Contribution to journalReview articlepeer-review

37 Citations (Scopus)

Abstract

Objectives: To analyze available evidence on vaccinations in paediatric patients with rheumatic and autoinflammatory diseases. This evidence formed the basis of the recently constructed European League against Rheumatism (EULAR) recommendations for vaccination of these patients. Methods: A systematic literature review in the MEDLINE and EMBASE databases was conducted using various terms for vaccinations, paediatric rheumatic and autoinflammatory diseases and immunosuppressive drugs. Only papers on paediatric patients (<. 18. years of age) were selected. A panel of 13 experts in the field graded methodological quality and extracted data using predefined criteria. Results: 27 papers were available. No studies were found on autoinflammatory diseases. 14 studies considered live-attenuated vaccines. Evidence so far supports the safety and immunogenicity of non-live composite vaccines, although studies were underpowered to accurately assess safety. Live-attenuated vaccines did not cause disease flares or severe adverse events, not even in patients on methotrexate and low dose glucocorticosteroids. Seven patients on anti-TNFalpha therapy were described receiving the live-attenuated measles, mumps, rubella (n=5) or varicella (n=2) booster without severe adverse events. Conclusions: Data on safety and efficacy of vaccinations in paediatric patients with rheumatic diseases is reassuring, but too limited to draw definite conclusions. More research is needed on the safety and efficacy of especially live-attenuated vaccines in patients with rheumatic and autoinflammatory diseases using high dose immunosuppressive drugs.

Original languageEnglish
Pages (from-to)112-122
Number of pages11
JournalAutoimmunity Reviews
Volume11
Issue number2
DOIs
Publication statusPublished - Dec 2011

Keywords

  • Biologicals
  • Glucocorticosteroids
  • Immunosuppressive drugs
  • Live-attenuated vaccines
  • Pediatric rheumatic disease
  • Vaccination

Fingerprint

Dive into the research topics of 'Vaccination in paediatric patients with auto-immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendations'. Together they form a unique fingerprint.

Cite this